Skip to main content
Log in

Influence of thyrotropin-releasing hormone on experimental pancreatitis in rats

  • Original Papers
  • Published:
Research in Experimental Medicine

Abstract

The main purpose of this study was to investigate the influence of thyroid releasing hormone on acute sodium-taurocholate-induced pancreatitis in rats. Thyroid-releasing hormone did not change the survival rate, serum amylase, glucose calcium, liver transaminases levels or the degree of pancreatic damage, but reduced lactate dehydrogenase. Our findings suggest that the use of thyroid-releasing hormone has no beneficial effect on the course of acute experimental pancreatitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aho RJ, Nevalainen J (1980) Experimental pancreatitis in the rat: ultra structure of sodium taurocholate-induced pancreatic lesions. scand J Gastroenterol 15:417–424

    PubMed  CAS  Google Scholar 

  2. Alhan E, Özoran Y (1993) The influence of total parenteral nutrition on the experimental pancreatitis in rats. Res Exp Med 193:1–7

    Google Scholar 

  3. Alhan E, Alvur M, Bilgin N (1984) The effects of somatostatin on pancreatitis induced by blind loop in dogs. Doga Bilim Dergisi 1:1–3

    Google Scholar 

  4. Alto HJ, Koskensalo ML, Nevalainen TJ (1980) Experimental pancreatitis in the rat. Scand J Gastroenterol 15:411–416

    Article  Google Scholar 

  5. Ashmarin JP, Gurskaia IE, Guseva AA, Lelekova TV, et al. (1992) Thyroliberin: new physiological effects and prospects. Vestn Ross Akad Med Nauk 6:40–44

    PubMed  Google Scholar 

  6. Bradley EL, Salam AA (1978) Hyperbilurubinemia in inflammatory pancreatic disease; natural history and management. Ann Surg 188:625–629

    Article  Google Scholar 

  7. Broziony J, Schwille PO (1985) Subcutaneous cannula in the jugular vein and femoral vein—a tool for frequent sampling and infusions in the rat. Z Versuchstierkd 27:29–3266

    Google Scholar 

  8. Ceylan S, Ilbay K, Baykal S, Ceylan S (1992) Treatment of acute spinal cord injuries comparison of thyrotropin-releasing hormone and nimodipine. Res Exp Med 192:23–33

    CAS  Google Scholar 

  9. Florez J, Mediavilla, A (1977) Respiratory and cardiovascular effects of metenkephalin applied to the ventral surface of the brain stem. Brain Res 138:585–590

    Article  PubMed  CAS  Google Scholar 

  10. Friedman LM (1985) Survival analysis. In: Friedman LM (ed) Fundamentals of clinical trials, 3rd edn. PSG Publishing, Boston, Mass, pp 191–203

    Google Scholar 

  11. Gullo L, Labo G (1981) Thyrotropin-releasing hormone inhibits pancreatic enzyme secretion in humans. Gastroenterology 80:735–739

    PubMed  CAS  Google Scholar 

  12. Gurrl NJ, Holaday JW, Reynolds DG, Ganes E (1987) Thyrotropin releasing hormone: effects in monkey and dogs subjected to experimental circulatory shock. Crit Care Med 15:574–581

    Article  Google Scholar 

  13. Hock CE, Lefer AM (1985) Lack of effect of thyrotropin releasing hormone (TRH) in circulatory shock. Peptides 6:547–553

    Article  PubMed  CAS  Google Scholar 

  14. Holaday JW (1984) Opiate antagonist in shock and trauma. Am J Emerg Med 2:8–12

    Article  PubMed  CAS  Google Scholar 

  15. Lankisch PG, Winckler K, Bokermann M, Schmidt H (1974) The influence of glucagon on acute experimental pancreatitis in the rat. Scand J Gastroenterol 9:725–729

    PubMed  CAS  Google Scholar 

  16. Perez-Matero M, Bouxi V, Martinez A, Latour J (1991) A critical analysis of clinical trials in acute pancreatitis published between 1983 and 1989. Med Clin (Barc) 96:371–373

    Google Scholar 

  17. Ranson JHC, Rifkind KM, Roses DF (1974) Prognostic signs and the role of operative management in acute pancreatitis, Surg Gynecol Obstet 139:69–81

    PubMed  CAS  Google Scholar 

  18. Satake K, Hiura A, Nishiwaki H, et al, (1989) Plasma beta-endorphin and the effect of naloxone on hemodynamic changes during experimental acute pancreatitis in dogs. Surg Gynecol Obstet 168:402–406

    PubMed  CAS  Google Scholar 

  19. Shimanko II, Limarev VM, Ashmarin IP, et al (1992) The use of thyrotropin-releasing hormone in clinical practice as a lymphatic stimulator in the treatment of acute pancreatitis. Khirurgiia 1:64–67

    PubMed  Google Scholar 

  20. Siren AL (1988) Cardiovascular pharmacology of thyrotropin-releasing hormone. Peptides 9:69–73

    Article  PubMed  Google Scholar 

  21. Siren AL, Powel E, Feuersten G (1986) Thyrotropin releasing hormone in hypovolemia: a hemodynamic evaluation in the rat. Am J Physiol 250:1093–1101

    Google Scholar 

  22. Stanfield NJ, Kakkar VV (1983) Prostaglandins and acute pancreatitis—experimental and clinical studies. Br J Surg 70:573–576

    Article  Google Scholar 

  23. Winiger BP, Schlegel W (1988) Rapid transient elevations of cystosolic calcium triggered by thyroid releasing hormone in individual cells of the pituitary line. Biochem J 255: 161–167

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alhan, E., Küçüktülü, U., Çalik, A. et al. Influence of thyrotropin-releasing hormone on experimental pancreatitis in rats. Res. Exp. Med. 195, 243–248 (1995). https://doi.org/10.1007/BF02576794

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02576794

Key words

Navigation